We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

66 hedge funds and large institutions have $180M invested in Syneron Medical Ltd in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

661% more call options, than puts

Call options by funds: $236K | Put options by funds: $31K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

16% less funds holding

Funds holding: 7966 (-13)

35% less capital invested

Capital invested by funds: $276M → $180M (-$95.9M)

76% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 17

Holders
66
Holders Change
-13
Holders Change %
-16.46%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
23
Reduced
24
Closed
17
Calls
$236K
Puts
$31K
Net Calls
+$205K
Net Calls Change
-$264K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$803K -$344K -35,800 -25%
TA
27
Teton Advisors
New York
$724K
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$616K -$10.6K -1,100 -1%
DCM
29
DAFNA Capital Management
California
$615K -$48K -5,000 -5%
LAM
30
Lapides Asset Management
Connecticut
$548K +$736K +76,600 New
BIM
31
Bogle Investment Management
Massachusetts
$506K -$356K -37,089 -34%
WA
32
Whitebox Advisors
Minnesota
$497K -$52K -5,410 -7%
PIM
33
Profit Investment Management
Maryland
$477K -$157K -16,333 -20%
QI
34
QS Investors
New York
$463K -$77.1K -8,025 -11%
MC
35
Moors & Cabot
Massachusetts
$437K +$7.69K +800 +1%
GCP
36
GSA Capital Partners
United Kingdom
$432K +$174K +18,151 +43%
OAM
37
Oxford Asset Management
United Kingdom
$361K -$436K -45,420 -47%
NCCM
38
Nine Chapters Capital Management
New Jersey
$321K -$63.4K -6,600 -13%
Creative Planning
39
Creative Planning
Kansas
$174K +$233K +24,300 New
GI
40
GAMCO Investors
Connecticut
$172K
State Street
41
State Street
Massachusetts
$155K
Invesco
42
Invesco
Georgia
$147K +$6.69K +696 +4%
Geode Capital Management
43
Geode Capital Management
Massachusetts
$142K +$83.2K +8,661 +76%
Goldman Sachs
44
Goldman Sachs
New York
$138K -$96.8K -10,074 -34%
TC
45
TFS Capital
Pennsylvania
$127K +$71.5K +7,441 +73%
PP
46
PDT Partners
New York
$124K -$4.75K -494 -3%
BG
47
BlackRock Group
United Kingdom
$118K
COPPSERS
48
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$114K
ARTA
49
A.R.T. Advisors
New York
$110K -$8.06K -839 -5%
SCM
50
Stevens Capital Management
Pennsylvania
$108K +$9.09K +946 +7%

ELOS Hedge Fund Activity: Q3 2015 in Review

66 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2015, worth a combined $180M — down 35% from $276M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ELOS and 4 opened new positions — a net loss of 13 holders — while 24 trimmed existing stakes and 23 added.

The largest buyer was Dalton, Greiner, Hartman, Maher & Co, adding an estimated $3.16M. The largest seller was Visium Asset Management, exiting entirely with an estimated $10.6M sold.

  • 66 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2015, down from 79 in Q2 2015.
  • Funds reported $180M of Syneron Medical Ltd stock for Q3 2015, down 35% quarter-over-quarter.
  • 4 funds opened new Syneron Medical Ltd positions in Q3 2015 and 17 closed out, a net change of -13 holders.
  • The largest Syneron Medical Ltd buyer in Q3 2015 was Dalton, Greiner, Hartman, Maher & Co, an estimated $3.16M added.
  • The largest Syneron Medical Ltd seller in Q3 2015 was Visium Asset Management, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2015.